Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Andreas Fontalis, Eustathios Kenanidis, Efthymia Prousali, Michael Potoupnis & Eleftherios Tsiridis. (2018) Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis. Expert Opinion on Drug Safety 17:4, pages 413-428.
Read now
Read now
Masashi Uehara, Yukio Nakamura, Jun Takahashi, Fumihiro Isobe, Shota Ikegami, Takako Suzuki, Shigeharu Uchiyama, Mikio Kamimura & Hiroyuki Kato. (2018) Efficacy of teriparatide and denosumab combination treatment in a patient with atypical femoral fracture and Behçet’s disease: a case report and review of the literature. Modern Rheumatology Case Reports 2:1, pages 92-96.
Read now
Read now
Articles from other publishers (36)
Safoora Poorirani, Sayed latif Taheri & Sayed Abolfazl Mostafavi. (2022) Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis. Osteoporosis International 34:2, pages 255-267.
Crossref
Crossref
Adnin Zaman, Micol S. Rothman & Sarah J. Billups. (2022) Stop the denosumab delay! The effect of implementing an automatic reminder in the electronic medical record. Archives of Osteoporosis 17:1.
Crossref
Crossref
Qin Xu, Dan Li, Jing Chen, Ju Yang, Jiai Yan, Yanping Xia, Feng Zhang, Xuesong Wang & Hong Cao. (2022) Crosstalk between the gut microbiota and postmenopausal osteoporosis: Mechanisms and applications. International Immunopharmacology 110, pages 108998.
Crossref
Crossref
Kai Yang, Shunyao Li, Tianqi Wang, Xueming Yan, Qian He, Ruonan Ning, Xing Xu, Wei Yao, Xiaofei Zhang, Chunhao Yang, Min Jiang & Lianfu Deng. (2022) Development of an Orally Active Small-Molecule Inhibitor of Receptor Activator of Nuclear Factor-κB Ligand. Journal of Medicinal Chemistry 65:16, pages 10992-11009.
Crossref
Crossref
Jun Hou, Hongjie Su, Xiaocong Kuang, Wencong Qin, Kaibing Liu, Kaixiang Pan, Bokai Zhang, Sijie Yang, Shenghui Yang, Xiao Peng, Xinyu Nie & Qikai Hua. (2022) Knowledge Domains and Emerging Trends of Osteoblasts-Osteoclasts in Bone Disease From 2002 to 2021: A Bibliometrics Analysis and Visualization Study. Frontiers in Endocrinology 13.
Crossref
Crossref
Liang Tang, Tianpei Wu, Yaling Zhou, Yi Zhong, Lijun Sun, Jianzhong Guo, Xiushan Fan & Dean Ta. (2022) Study on synergistic effects of carboxymethyl cellulose and LIPUS for bone tissue engineering. Carbohydrate Polymers 286, pages 119278.
Crossref
Crossref
Ahmed E. Noreldin, Islam M. Saadeldin, Norhan E. Khalifa & Asmaa F. Khafaga. (2022) Emerging Therapeutic Potential of Short Mitochondrial-produced Peptides for Anabolic Osteogenesis. International Journal of Peptide Research and Therapeutics 28:1.
Crossref
Crossref
Liang Tang, Shasha An, Zhihao Zhang, Xiushan Fan, Jianzhong Guo, Lijun Sun & Dean Ta. (2021) MSTN is a key mediator for low-intensity pulsed ultrasound preventing bone loss in hindlimb-suspended rats. Bone 143, pages 115610.
Crossref
Crossref
Charat Thongprayoon, Prakrati Acharya, Narothama Reddy Aeddula, Aldo Torres-Ortiz, Tarun Bathini, Konika Sharma, Patompong Ungprasert, Kanramon Watthanasuntorn, Maria Lourdes Gonzalez Suarez, Sohail Abdul Salim, Wisit Kaewput, Jirat Chenbhanich, Michael A. Mao & Wisit Cheungpasitporn. (2019) Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis. Archives of Osteoporosis 14:1.
Crossref
Crossref
Luc Rochette, Alexandre Meloux, Eve Rigal, Marianne Zeller, Gabriel Malka, Yves Cottin & Catherine Vergely. (2019) The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics. Calcified Tissue International 105:3, pages 239-251.
Crossref
Crossref
Juliane Medler, Johannes Nelke, Daniela Weisenberger, Tim Steinfatt, Moritz Rothaug, Susanne Berr, Thomas Hünig, Andreas Beilhack & Harald Wajant. (2019) TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity. Cell Death & Disease 10:3.
Crossref
Crossref
Ichiro Abe, Kentaro Ochi, Yuichi Takashi, Yuka Yamao, Hanako Ohishi, Hideyuki Fujii, Midori Minezaki, Kaoru Sugimoto, Tadachika Kudo, Makiko Abe, Yasushi Ohnishi, Shigeaki Mukoubara & Kunihisa Kobayashi. (2019) Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters. Medicine 98:47, pages e18067.
Crossref
Crossref
Sana Javed, Ayesha Sohail & Alessandro Nutini. (2018) Integrative modeling of drug therapy and the bone turnover. Clinical Biomechanics 60, pages 141-148.
Crossref
Crossref
C. Thongprayoon, P. Acharya, C. Acharya, J. Chenbhanich, T. Bathini, B. Boonpheng, K. Sharma, K. Wijarnpreecha, P. Ungprasert, M.L. Gonzalez Suarez & W. Cheungpasitporn. (2018) Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies. Osteoporosis International 29:8, pages 1737-1745.
Crossref
Crossref
Daiki Kumaki, Yukio Nakamura, Noriko Sakai, Tomoki Kosho, Akinori Nakamura, Shinichi Hirabayashi, Takako Suzuki, Mikio Kamimura & Hiroyuki Kato. (2018) Efficacy of Denosumab for Glucocorticoid-Induced Osteoporosis in an Adolescent Patient with Duchenne Muscular Dystrophy. JBJS Case Connector 8:2, pages e22-e22.
Crossref
Crossref
Yukio Nakamura, Takako Suzuki, Mikio Kamimura, Kohei Murakami, Shota Ikegami, Shigeharu Uchiyama & Hiroyuki Kato. (2017) Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment. Bone Research 5:1.
Crossref
Crossref
Takako Suzuki, Yukio Nakamura & Hiroyuki Kato. (2017) Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients. Nutrients 9:8, pages 871.
Crossref
Crossref
Yukio Nakamura, Takako Suzuki, Tomohiko Yoshida, Hideshi Yamazaki & Hiroyuki Kato. (2017) Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis. Nutrients 9:5, pages 428.
Crossref
Crossref
Beata Znorko, Ewa Oksztulska-Kolanek, Małgorzata Michałowska, Tomasz Kamiński & Krystyna Pawlak. (2017) Does the OPG/RANKL system contribute to the bone-vascular axis in chronic kidney disease? A systematic review. Advances in Medical Sciences 62:1, pages 52-64.
Crossref
Crossref
F. Vescini, R. Attanasio, A. Balestrieri, F. Bandeira, S. Bonadonna, V. Camozzi, S. Cassibba, R. Cesareo, I. Chiodini, C. Maria Francucci, L. Gianotti, F. Grimaldi, R. Guglielmi, B. Madeo, C. Marcocci, A. Palermo, A. Scillitani, E. Vignali, V. Rochira & M. Zini. (2016) Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis. Journal of Endocrinological Investigation 39:7, pages 807-834.
Crossref
Crossref
Madhusmita Misra, Neville H. Golden & Debra K. Katzman. (2016) State of the art systematic review of bone disease in anorexia nervosa. International Journal of Eating Disorders 49:3, pages 276-292.
Crossref
Crossref
S. K. Ramchand, C. Y. Chiang, R. M. Zebaze & E. Seeman. (2015) Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report. Osteoporosis International 27:2, pages 821-825.
Crossref
Crossref
Andrés Felipe Posada, Hernán Darío Aguirre, Julio Cesar García Casallas, Jhon Darío Lodoño Patiño & Rafael Valle Oñate. (2016) New therapies in osteoporosis. Revista Colombiana de Reumatología (English Edition) 23:1, pages 34-43.
Crossref
Crossref
Andrés Felipe Posada, Hernán Darío Aguirre, Julio Cesar García Casallas, Jhon Darío Lodoño Patiño & Rafael Valle Oñate. (2016) Nuevas terapias en osteoporosis. Revista Colombiana de Reumatología 23:1, pages 34-43.
Crossref
Crossref
Gustavo Duque, Pushpa Suriyaarachchi, Piumali Gunawardene & Oddom Demontiero. 2016. Osteoporosis in Older Persons. Osteoporosis in Older Persons
229
241
.
Vishwa Deepak, Marlena C. Kruger, Annie Joubert & Magdalena Coetzee. (2015) Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis. BioFactors 41:6, pages 403-413.
Crossref
Crossref
Małgorzata Michałowska, Beata Znorko, Ewa Oksztulska-Kolanek, Tomasz Kamiński & Dariusz Pawlak. (2015) A view at monoclonal antibodies in therapy of osteoporosis. Polish Annals of Medicine 22:2, pages 149-154.
Crossref
Crossref
Bente L. Langdahl. (2015) New treatments of osteoporosis. Osteoporosis and Sarcopenia 1:1, pages 4-21.
Crossref
Crossref
Kareeann Sok Fun Khow & Tuck Yean Yong. (2014) Atypical femoral fracture in a patient treated with denosumab. Journal of Bone and Mineral Metabolism 33:3, pages 355-358.
Crossref
Crossref
Vatsa Dave, Cherie Y. Chiang, Jane Booth & Peter F. Mount. (2015) Hypocalcemia Post Denosumab in Patients with Chronic Kidney Disease Stage 4-5. American Journal of Nephrology 41:2, pages 129-137.
Crossref
Crossref
Francesca Marini & Maria Luisa Brandi. (2014) Pharmacogenetics of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 783-793.
Crossref
Crossref
R. Galindo Zavala, E. Núñez Cuadros, G. Díaz Cordovés-Rego & A.L. Urda Cardona. (2014) Avances en el tratamiento de la osteoporosis secundaria. Anales de Pediatría 81:6, pages 399.e1-399.e7.
Crossref
Crossref
N. Dehamchia-Rehailia, D. Ursu, I. Henry-Desailly, P. Fardellone & J. Paccou. (2014) Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital’s fracture liaison service between January 2010 and December 2011. Osteoporosis International 25:10, pages 2409-2416.
Crossref
Crossref
M. Misra & A. Klibanski. (2014) Anorexia nervosa and bone. Journal of Endocrinology 221:3, pages R163-R176.
Crossref
Crossref
Francesca Marini & Maria Luisa Brandi. (2014) WITHDRAWN: Pharmacogenetics of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism.
Crossref
Crossref
Nasser Mikhail. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.